|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Iron Deficiency Anemia | |||||
| Iron Deficiency | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Anemia | |||||
| Anemia, Iron-Deficiency | |||||
| Deficiency Diseases | |||||
| 3 | More general conditions related to this trial | ||||
| Anemia, Hypochromic | |||||
| Hematologic Diseases | |||||
| Iron Metabolism Disorders | |||||
| Malnutrition | |||||
| Metabolic Diseases | |||||
| Nutrition Disorders | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Folic Acid | |||||
| Iron | |||||
| Retinol palmitate | |||||
| Vitamin A | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anticarcinogenic Agents | |||||
| Antineoplastic Agents | |||||
| Antioxidants | |||||
| Growth Substances | |||||
| Hematinics | |||||
| Hematologic Agents | |||||
| Micronutrients | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protective Agents | |||||
| Therapeutic Uses | |||||
| Trace Elements | |||||
| Vitamin B Complex | |||||
| Vitamins | |||||
| 6 | Sponsors listed in this trial | ||||
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | |||||
| Centers for Disease Control and Prevention | |||||